論文]
[論文]
1）
Tanaka
M, Komaba H, Itoh K, Matsushita K, Matsushita K, Hamada Y, Fujii H, Fukagawa M:
The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary
hyperparathyroidism: Nephrol Dial Transplant Plus,
2008
2）
Tanaka M, Fukagawa M: Medical
management after parathyroid intervention: Nephrol Dial Transplant Plus,
2008
3）
Tanaka M , Nakanishi S, Ito K,
Matsushita K, Komaba H, Fukagawa M: Association between Long-term Efficacy of
Cinacalcet and Parathyroid Gland Volume in Haemodialysis Patients with Secondary
Hyperparathyroidism: Nephrol Dial Transplant Plus,
2008
4）
Tanaka M, Fukaagwa M: Treatment
of secondary hyperparathyroidism of dialysis patients with calcimimetics.
CLINICAL CALCIUM, 2008
5）
Itoh K, Tanaka M, et al:
Comparison of sevelamer hydrochloride with colestimide, administered alone or in
combination with calcium carbonate, in patients on haemodialysis. Prospective
randomised controlled multicentre study: Ther Apher Dial,
2008
6）
Komaba H, Tanaka M, Fukagawa M:
Treatment of Chronic Kidney
Disease-Mineral and Bone Disorder (CKD-MBD), Intern Med,
2008
7）
Fukagawa M, Yumita S,
Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S; KRN1493 study group.:
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with
favorable control of the serum phosphorus and calcium levels in Japanese
dialysis patients. Nephrol Dial Transplant 23, 328-335, 2008
8）
Tsuchihashi D, Abe T, Komaba H,
Fujii H, Hamada Y, Nii-Kono T, Tanaka M, Fukagawa M: Serum pro-hepcidin as an
indicator of iron status in hemodialysis patients: Ther Apher Dial,
2008
9） Shimotori
M, Maruyama H, Nakamura G, Suyama T, Sakamoto F, Itoh M, Miyabayashi S, Ohnishi T, Sakai N, Wataya-Kaneda M, Kubota M, Takahashi T, Mori T, Tamura K, Kageyama S, Shio N, Maeba T, Yahagi H, Tanaka M, Oka M, Sugiyama H, Sugawara T, Mori N, Tsukamoto H, Tamagaki K, Tanda S, Suzuki Y, Shinonaga C, Miyazaki J, Ishii S, Gejyo F.: Novel mutations of the GLA
gene in Japanese patients with Fabry disease and their functional
characterization by active site specific chaperone.
Hum Mutat.
2008;29:331.
10）
Fujii H, Fukuda A, Tanaka M, Kojima Y, Ishida T,
Hirata KI, Fukagawa M.: Putative Role of Endothelial Lipase in Dialysis Patients
with Hypoalbuminemia and Inflammation.: Am J Nephrol. 2008: 28:974-981.
11）
田中元子、伊藤和子、松下和孝：当院において選択的副甲状腺PEITを施行した30症例の治療経過についての検討：腎と骨代謝21：86,
2008
12）
秋澤忠男、栗原怜、伊丹儀友、横山啓太郎、重松隆、風間順一郎、田中元子、各田隆俊：第26回仁と骨代謝研究会学術集会ワークショップ―ガイドライン進化へのプロローグ。腎と骨代謝21,
2008
13）
田中元子：腎疾患コンサルテーション
14）
伊藤和子：腎疾患コンサルテーション
15）
田中元子：副甲状腺インターベンションガイド
16）
田中元子：薬局